Scorpio Ip Limited opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Scorpio Ip Limited

Patent Number:
Title:
Bispecific Antibodies Against Cd3Epsilon And Bcma For Use In Treatment Of Diseases
Opposition Date:
May 16, 2024
Patent Number:
Title:
Method For Preparing Tert-Butyl N-((1R,2S,5S)-2-((2-((5-Chloropyridin-2-Yl)Amino)-2-Oxoacetyl)Amino)-5-(Dimethylcarbamoyl)Cyclohexyl)Carbamate
Opposition Date:
Dec 8, 2023
Patent Number:
Title:
Crystalline L-Arginine Salt Of (R)-2-(7-(4-Cyclopentyl-3-(Trifluoromethyl)Benzyloxy)-1,2,3,4-Tetrahydrocyclo-Penta[B]Indol-3-Yl)Acetic Acid(Compound1) For Use In Sipi Receptor-Associated Disorders
Opposition Date:
Jun 14, 2023
Patent Number:
Title:
Rapid-Acting Insulin Compositions
Opposition Date:
Dec 30, 2022
Patent Number:
Title:
Process For The Preparation Of (1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-Phenol
Opposition Date:
Aug 16, 2022
Patent Number:
Title:
Dosage Regimen For Anti-Mif Antibodies
Applicant:
Opposition Date:
Dec 24, 2021
Patent Number:
Title:
Power Tool
Opposition Date:
Dec 6, 2021
Patent Number:
Title:
Machine Tool That Can Be Guided Manually And Having A Housing
Opposition Date:
Sep 30, 2021
Patent Number:
Title:
Insulin Formulations For Rapid Uptake
Opposition Date:
Aug 16, 2021
Patent Number:
Title:
Power Tool
Opposition Date:
Jun 8, 2021

Want to track Scorpio Ip Limited?

Feel free to send us a message here and we will get back to you